Deep Dive Report: TrimRx — GLP-1 Telehealth Weight Loss Subscription Analysis

Premium Content

Upgrade to unlock all in-depth reports

Upgrade NowView Pricing Plans
SaaS

Deep Dive Report: TrimRx — GLP-1 Telehealth Weight Loss Subscription Analysis

ProfitSearcher 研究团队
2026-03-23
8 min

Deep Dive Report: TrimRx — GLP-1 Telehealth Weight Loss Subscription Analysis

1. Background

TrimRx (trimrx.com) is a US telehealth platform specializing in GLP-1 medications (Semaglutide, Tirzepatide) for weight loss through a fully digital process — no in-person clinic visits required.

Key Metrics:

  • MRR: $277,974 (March 2026)
  • MoM Growth: +20%
  • Monthly Visits: 2.03M
  • US Users: 92.3%
  • Launch: ~November 2024 (GLP-1 pivot)
  • Pricing: from $179/month (Semaglutide)

2. Product Breakdown

Digital User Journey:

  1. Online health assessment (BMI, medical history, ~10 min questionnaire)
  2. Async physician review (licensed doctor, 24-48 hours)
  3. Personalized Semaglutide/Tirzepatide prescription
  4. Medication mailed directly home from licensed compounding pharmacy
  5. Ongoing care team follow-up (dosage adjustments, nutrition guidance)

Differentiation: $179/month vs. $300-500/month at traditional clinics; fully online; compounded Semaglutide at lower cost than brand-name Ozempic.

3. Business Model

Estimated Pricing:

  • Semaglutide pl

Premium Content

Upgrade to unlock all in-depth reports

Upgrade Now

Want more business insights?

Subscribe to ProfitSearcher for weekly business opportunities and in-depth analysis

Start Free Trial